Viatris Wins U.S. FDA Approval for Gwyn Lo Contraceptive
PITTSBURGH, July 29, 2026 Viatris Inc. has received U.S. Food and Drug Administration (FDA) approval for Gwyn Lo™ (norelgestromin...
U.S. FDA approval
Advertisement
Lupin Wins FDA Approval for Ranluspec Biosimilar Eye Drug
Mumbai, India and Naples, Florida, June 5, 2026 Global pharmaceutical company Lupin Limited has secured a major regulatory milestone...
Lupin Wins U.S. FDA Approval for Famotidine Injection
MUMBAI, India and NAPLES, Fla., May 13, 2026 Global pharmaceutical company Lupin Limited announced that it has received approval...
FDA Approves J&J’s INLEXZO™, Redefining Bladder Cancer Care
September 9, 2025 – Raritan, N.J. – In a landmark regulatory milestone, Johnson & Johnson (NYSE: JNJ) announced U.S....
Lupin Wins U.S. FDA Approval for First Nanomi LAI Injectable
September 3, 2025 – Mumbai & Naples – Lupin Limited announced U.S. FDA approval for its Risperidone extended-release injectable...
Advertisement
